HeathTell Inc. Expands Executive Team with Bob Barrett as New VP of Marketing and Commercial Operations

Saturday, August 6, 2016 General News J E 4
Diagnostic Industry Veteran Will Help Drive Commercialization of Tests Based on Novel Profiling of the Immune System

SAN RAMON, Calif., Aug. 5, 2016 /PRNewswire/ -- HealthTell, Inc., a company developing diagnostic, prognostic and monitoring tests for complex immune mediated diseases, today announced it has appointed Bob Barrett as the company's Vice President of Marketing and Commercial Operations.

At HealthTell, Barrett will apply his extensive marketing experience to help commercialize the company's next-generation diagnostic tests. 

"I'm delighted to welcome Bob to the HealthTell team," said HealthTell CEO, Bill Colston.  "Over the past few years the company has made rapid progress in developing our unique Immunosignature™ platform.  Bob will be instrumental in introducing these novel tests to physicians, patients and payers."

Barrett is a diagnostic industry veteran with over 30 years of commercialization experience in Life Sciences and Clinical Diagnostics.  He has held executive commercial positions at leading companies including: Chiron, Roche, Qiagen, and Applied Biosystems/LIFE Technologies. In one of his early positions, Bob helped execute the market development strategy for HIV and HCV viral load tests, and was the first head of Commercial Operations during the launch of molecular testing technologies into blood banks.

"I'm very excited to be join HealthTell's executive team," said Barrett.  "I consider HealthTell to be a company that has the potential to become a leader in the molecular diagnostic segment. This was an opportunity I could not pass up. There is a great deal of energy, passion and commitment from every employee in this company."

About HealthTell, Inc.

HealthTell is committed to empowering the next generation of diagnostics and therapeutics for complex immune-mediated diseases such as cancer, autoimmune disorders, and infectious diseases. Based on robust proprietary technology, HealthTell is developing the first and only diagnostic platform capable of assessing an individual's immune system response to specific diseases. Applicable to a broad range of therapeutic areas, HealthTell is empowering physicians and patients to proactively manage health and make more informed decisions. For more information, please visit:

To view the original version on PR Newswire, visit:

SOURCE HealthTell, Inc.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Advisory - Pharmascience Inc. voluntarily recalls ...
Highland and Acadia Healthcare Sign Letter of Inte...